Dr Nigel FullwoodSenior Lecturer
Dr Fullwood is a cell biologist working on various aspects of the eye, in particular the cornea. He especially interested in the development and refinement of stem cell therapies for eye disease and the development of an artificial cornea. He also carries out extensive research into the causes of eye disease.
I am involved in the development of therapies for the preservation and restoration of sight. I have long term collaboration in this area with Kyoto Prefectural Medical University I am currently involved in several projects, listed below.
- The identification and characterisation of stem cells
- Research into the causes of corneal dysfunction.
- Corneal transplantation.
- Development of an artificial cornea.
- Development of corneal stem cell therapies.
- Development of an in vitro model of the eye.
I am currently funded by the Royal Society, the BBSRC and the EPSRC. Research and graduate student positions are sometimes available in these research areas. I am also on the steering committee of the N8 Centre for Translational Regenerative Medicine which has recently received 2 million phase II funding.
Honours and Prizes
Award of 2004 Daiwa Adrian prize as part of a four person international team working on Corneal Diseases, presented at the Royal Society on 25th November 2004. Fellow of the Royal Microscopy Society. Visiting Scientist at Kyoto Prefectural University of Medicine, Japan
I teach courses on cell biology, biomedicine and microscopy at the undergraduate and postgraduate level. These include BIOL 112 (Module director), BIOL 211, BIOL 363, BIOL 315 (Module director), BIOL 464 (Module director) Biol 466 (Module director). I am Director of Studies for the MSc Degree in Biomedicine
- BSc Joint Hons. Genetics and Cell Biology. University of Manchester. 1982
- MPhil Physiology. CNAA. 1989
- PhD Biophysics. Oxford Research Unit, Open University. 1992
PhD Supervision Interests
Projects are available in the field of stem cell therapies for the treatment of corneal eye disease in collaboration with Kyoto Prefectural University of Medicine, Japan.
Peptide inhibitors of tau aggregation as a potential treatment for Alzheimer’s disease
01/02/2020 → 31/01/2022
Defying Dementia: Preliminary studies into peptide-based inhibitors of Tau aggregation
01/07/2018 → 31/12/2018